Article

Bufei Qingyu Granules Inhibit the Development of Systemic Sclerosis via Notch-1/Jagged-2…

Evidence-Based Complementary and Alternative Medicine · 2019 · Minhui Su, author Fang Tian, author Bingchen Ouyang, author Xiaoyu Wu, author Feng Guo, author Hua Chen, author Xuejun Zhu, author Jianmei Chen, author Xian Qian, author Yuewen Gong, Academic Editor

Key facts

Title Bufei Qingyu Granules Inhibit the Development of Systemic Sclerosis via Notch-1/Jagged-2 Signaling Pathway
First author Minhui Su, author Fang Tian, author Bingchen Ouyang, author Xiaoyu Wu, author Feng Guo, author Hua Chen, author Xuejun Zhu, author Jianmei Chen, author Xian Qian, author Yuewen Gong, Academic Editor
Journal Evidence-Based Complementary and Alternative Medicine
Published Jan 7, 2019
DOI 10.1155/2019/6709278
Devices mentioned K810863, K973350, K990827
Product codes mentioned DBM, JJQ, JQW, JLX, KQP

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature